These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1248 related items for PubMed ID: 15603861

  • 21. A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.
    Pignata S, Breda E, Scambia G, Pisano C, Zagonel V, Lorusso D, Greggi S, De Vivo R, Ferrandina G, Gallo C, Perrone F.
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):229-36. PubMed ID: 18243011
    [Abstract] [Full Text] [Related]

  • 22. Paclitaxel (1-hour infusion) plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter phase II trial.
    Greco FA, Hainsworth JD.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-14-S12-17. PubMed ID: 9331113
    [Abstract] [Full Text] [Related]

  • 23. Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II.
    Blumenschein GR, Khuri FR, von Pawel J, Gatzemeier U, Miller WH, Jotte RM, Le Treut J, Sun SL, Zhang JK, Dziewanowska ZE, Negro-Vilar A.
    J Clin Oncol; 2008 Apr 10; 26(11):1879-85. PubMed ID: 18398153
    [Abstract] [Full Text] [Related]

  • 24. Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials.
    DeVore RF, Jagasia M, Johnson DH.
    Semin Oncol; 1997 Aug 10; 24(4 Suppl 12):S12-27-S12-29. PubMed ID: 9331116
    [Abstract] [Full Text] [Related]

  • 25. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
    Wang WH, Bao Y, Chen M, Zhang L, Li KX, Xu GC, Deng XW, Lu TX, Cui NJ.
    Ai Zheng; 2006 Oct 10; 25(10):1279-83. PubMed ID: 17059776
    [Abstract] [Full Text] [Related]

  • 26. Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer.
    Mori K, Kamiyama Y, Kondo T, Kano Y, Kodama T.
    Cancer Chemother Pharmacol; 2006 Jul 10; 58(1):86-90. PubMed ID: 16447041
    [Abstract] [Full Text] [Related]

  • 27. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
    Herbst RS, Hammond LA, Carbone DP, Tran HT, Holroyd KJ, Desai A, Williams JI, Bekele BN, Hait H, Allgood V, Solomon S, Schiller JH.
    Clin Cancer Res; 2003 Sep 15; 9(11):4108-15. PubMed ID: 14519633
    [Abstract] [Full Text] [Related]

  • 28. [Safety evaluation of adjuvant chemotherapy by weekly paclitaxel combined with weekly carboplatin in patients with postoperative non-small cell lung cancer].
    Hirose T, Nagao T, Kajikawa A, Sumi T, Sugimoto T, Hirose Y, Yoshida M, Kenzaki K.
    Gan To Kagaku Ryoho; 2007 Sep 15; 34(9):1397-400. PubMed ID: 17876136
    [Abstract] [Full Text] [Related]

  • 29. A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer.
    Inoue A, Usui K, Ishimoto O, Matsubara N, Tanaka M, Kanbe M, Gomi K, Koinumaru S, Saijo Y, Nukiwa T.
    Lung Cancer; 2006 Apr 15; 52(1):83-7. PubMed ID: 16483687
    [Abstract] [Full Text] [Related]

  • 30. Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer.
    Yumuk PF, Turhal NS, Gumus M, Hatabay NF, Turken O, Ozkan A, Salepci T, Aliustaoglu M, Ahiskali R.
    BMC Cancer; 2005 Jan 25; 5():10. PubMed ID: 15667664
    [Abstract] [Full Text] [Related]

  • 31. Results of a phase II study of weekly paclitaxel plus carboplatin in patients with extensive small-cell lung cancer with Eastern Cooperative Oncology Group Performance Status of 2, or age > or = 70 years.
    Neubauer M, Schwartz J, Caracandas J, Conkling P, Ilegbodu D, Tuttle T, Asmar L.
    J Clin Oncol; 2004 May 15; 22(10):1872-7. PubMed ID: 15143079
    [Abstract] [Full Text] [Related]

  • 32. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.
    Gynecol Oncol; 2005 Jan 15; 96(1):168-72. PubMed ID: 15589596
    [Abstract] [Full Text] [Related]

  • 33. A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC).
    Cohen RB, Langer CJ, Simon GR, Eisenberg PD, Hainsworth JD, Madajewicz S, Cosgriff TM, Pierce K, Xu H, Liau K, Healey D.
    Cancer Chemother Pharmacol; 2007 Jun 15; 60(1):81-9. PubMed ID: 17031646
    [Abstract] [Full Text] [Related]

  • 34. Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).
    Lilenbaum RC, Herndon JE, List MA, Desch C, Watson DM, Miller AA, Graziano SL, Perry MC, Saville W, Chahinian P, Weeks JC, Holland JC, Green MR.
    J Clin Oncol; 2005 Jan 01; 23(1):190-6. PubMed ID: 15625373
    [Abstract] [Full Text] [Related]

  • 35. Paclitaxel and carboplatin in inoperable non-small cell lung cancer.
    Kosmidis P, Mylonakis N, Fountzilas G, Samantas E, Athanasiadis A, Skarlos D.
    Semin Oncol; 1996 Dec 01; 23(6 Suppl 16):68-70. PubMed ID: 9007126
    [Abstract] [Full Text] [Related]

  • 36. Phase II study of carboplatin and weekly paclitaxel combination chemotherapy in advanced non-small cell lung cancer: a Kansai Clinical Oncology Group study.
    Hirabayashi M, Endoh K, Teramachi M, Okuda M, Yamaguchi K, Fukuda K, Tokuhisa H, Kagioka H, Nakai N, Nakade M.
    Lung Cancer; 2004 Jun 01; 44(3):355-62. PubMed ID: 15140549
    [Abstract] [Full Text] [Related]

  • 37. [Combination chemotherapy with carboplatin and weekly Paclitaxel in patients with advanced non-small cell lung cancer].
    Hashizume T, Ogura T, Kozawa S, Yamaguchi N, Hayashi M, Nakamura M, Miyazawa N, Watanuki Y, Takahashi H.
    Gan To Kagaku Ryoho; 2006 Apr 01; 33(4):471-5. PubMed ID: 16612156
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma.
    Nguyen NP, Leonardo JM, Karlsson U, Vos P, Bullock L, Thomas P, Lepera P, Ludin A, Chu C, Salehpour M, Jendrasiak G, Sallah S.
    Anticancer Res; 2002 Apr 01; 22(6B):3429-35. PubMed ID: 12552935
    [Abstract] [Full Text] [Related]

  • 39. Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer.
    Ceresoli GL, Gregorc V, Cordio S, Bencardino KB, Schipani S, Cozzarini C, Bordonaro R, Villa E.
    Lung Cancer; 2004 May 01; 44(2):231-9. PubMed ID: 15084388
    [Abstract] [Full Text] [Related]

  • 40. Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
    Goffin JR, Anderson IC, Supko JG, Eder JP, Shapiro GI, Lynch TJ, Shipp M, Johnson BE, Skarin AT.
    Clin Cancer Res; 2005 May 01; 11(9):3417-24. PubMed ID: 15867243
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 63.